Neurobiology of Disease, 0969-9961

Tidskrift

Fler filtreringsmöjligheter
  1. Prostaglandin E(2) and BDNF levels in rat hippocampus are negatively correlated with status epilepticus severity: No impact on survival of seizure-generated neurons.

    Maria Antonietta Ajmone-Cat, Robert Iosif, Christine Ekdahl Clementson, Zaal Kokaia, Luisa Minghetti & Olle Lindvall, 2006, I : Neurobiology of Disease. 23, 1, s. 23-35

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  2. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses

    Claudia G. Almeida, Davide Tampellini, Reisuke H. Takahashi, Paul Greengard, Michael T. Lin, Eric M. Snyder & Gunnar K. Gouras, 2005 nov, I : Neurobiology of Disease. 20, 2, s. 187-198

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-α-synuclein is normalized by LRRK2 modulation

    Michael Aagaard Andersen, Kenneth Vielsted Christensen, Lassina Badolo, Garrick Paul Smith, Ross Jeggo, Poul Henning Jensen, Kathrine Just Andersen & Florence Sotty, 2018 aug, I : Neurobiology of Disease. 116, s. 13-27 15 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Neuropathological and behavioral consequences of adeno-associated viral vector-mediated continuous intrastriatal neurotrophin delivery in a focal ischemia model in rats.

    Gunnar Andsberg, Zaal Kokaia, Ronald L Klein, Nicholas Muzyczka, Olle Lindvall & Ronald J Mandel, 2002, I : Neurobiology of Disease. 9, 2, s. 187-204

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Optogenetic inhibition of chemically induced hypersynchronized bursting in mice.

    Fredrik Berglind, Marco Ledri, Andreas Toft Sørensen, Litsa Nikitidou, Miriam Melis, Pascal Bielefeld, Deniz Kirik, Karl Deisseroth, My Andersson & Merab Kokaia, 2014, I : Neurobiology of Disease. 65, s. 133-141

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Dramatic differences in susceptibility to L-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion

    Francesco Bez, Veronica Francardo & Angela Cenci Nilsson, 2016 okt 1, I : Neurobiology of Disease. 94, s. 213-225 13 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease

    Anders Björklund, Carl Rosenblad, Christian Winkler & Deniz Kirik, 1997, I : Neurobiology of Disease. 4, 3-4, s. 186-200

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  8. Comparison of rating scales used to evaluate L-DOPA-induced dyskinesia in the 6-OHDA lesioned rat

    Ludivine S Breger, Stephen B Dunnett & Emma L Lane, 2013 feb, I : Neurobiology of Disease. 50, s. 142-50 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function.

    Kerstin Buck, Natalie Landeck, Ayse Ulusoy, Nour K Majbour, Omar M A El-Agnaf & Deniz Kirik, 2015, I : Neurobiology of Disease. 78, Mar 25, s. 100-114

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Apoptosis-inducing factor mediates dopaminergic cell death in response to lps-induced inflammatory stimulus Evidence in Parkinson's disease patients.

    Miguel Burguillos Garcia, N Hajji, E Englund, A Persson, Angela Cenci Nilsson, A Machado, J Cano, B Joseph & J L Venero, 2011, I : Neurobiology of Disease. 41, s. 177-188

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia.

    Thomas Carlsson, Christian Winkler, Martin Lundblad, Angela Cenci Nilsson, Anders Björklund & Deniz Kirik, 2006, I : Neurobiology of Disease. 21, 3, s. 657-668

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain

    Erik Cederfjäll, Gurdal Sahin & Deniz Kirik, 2012, I : Neurobiology of Disease. 48, 2, s. 222-227

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  13. Rodent models of impulsive compulsive behaviors in Parkinson's disease: how far have we reached?

    Angela Cenci Nilsson, Veronica Francardo, Sean S O'Sullivan & Hanna Lindgren, 2015, I : Neurobiology of Disease. 82, aug 29, s. 561-573

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  14. Inflammation without neuronal death triggers striatal neurogenesis comparable to stroke.

    Katie Chapman, Ruimin Ge, Emanuela Monni, Jemal Tatarishvili, Henrik Ahlenius, Andreas Arvidsson, Christine Ekdahl, Olle Lindvall & Zaal Kokaia, 2015, I : Neurobiology of Disease. 83, Aug 20, s. 1-15

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Cystamine/cysteamine rescues the dopaminergic system and shows neurorestorative properties in an animal model of Parkinson's disease.

    G Cisbani, Janelle Drouin-Ouellet, C Gibrat, M Saint-Pierre, M Lagacé, S Badrinarayanan, M H Lavallée-Bourget, J Charest, A Chabrat, L Boivin, M Lebel, M Bousquet, M Lévesque & F Cicchetti, 2015, I : Neurobiology of Disease. 82, s. 430-444

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.

    Mickael Decressac, Bengt Mattsson, Martin Lundblad, P Weikop & Anders Björklund, 2012, I : Neurobiology of Disease. 45, 3, s. 939-953

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Death mechanisms in status epilepticus-generated neurons and effects of additional seizures on their survival.

    Christine Ekdahl Clementson, Changlian Zhu, Sara Bonde, Ben A Bahr, Klas Blomgren & Olle Lindvall, 2003, I : Neurobiology of Disease. 14, 3, s. 513-523

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease

    Fabia Febbraro, Gurdal Sahin, Aina Farran, Sofia Soares, Poul H. Jensen, Deniz Kirik & Marina Romero-Ramos, 2013, I : Neurobiology of Disease. 56, s. 47-58

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.

    Veronica Francardo, Alessandra Recchia, Nataljia Popovic, Daniel Andersson, Hans Nissbrandt & Angela Cenci Nilsson, 2011, I : Neurobiology of Disease. 42, s. 327-340

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Nerve growth factor promotes survival of new neurons in the adult hippocampus.

    Helena Frielingsdorf, Daniel R Simpson, Leon J Thal & Donald P Pizzo, 2007, I : Neurobiology of Disease. 26, 1, s. 47-55

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.

    Joana Gil, Paul Mohapel, Ines Araujo, Natalija Popovic, Jia-Yi Li, Patrik Brundin & Åsa Petersén, 2005, I : Neurobiology of Disease. 20, 3, s. 744-751

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Kindling alters entorhinal cortex-hippocampal interaction by increased efficacy of presynaptic GABA(B) autoreceptors in layer III of the entorhinal cortex

    T Gloveli, J Behr, T Dugladze, Zaal Kokaia, Merab Kokaia & U Heinemann, 2003, I : Neurobiology of Disease. 13, 3, s. 203-212

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures

    Casper R. Gotzsche, Litsa Nikitidou, Andreas Toft Sörensen, Mikkel V. Olesen, Gunnar Sorensen, Soren H. O. Christiansen, Mikael Ängehagen, David P. D. Woldbye & Merab Kokaia, 2012, I : Neurobiology of Disease. 45, 1, s. 288-296

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Heritability and genetic variance of dementia with Lewy bodies

    Rita Guerreiro, Elisabet Londos, Jose Bras & International Parkinson's Disease Genomics Consortium (IPDGC) International Parkinson's Disease Genomics Consortium (IPDGC), 2019, I : Neurobiology of Disease. 127, s. 492-501 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP.

    Christian Hansen, Tomas Björklund, Géraldine Petit, Martin Lundblad, Reena Murmu, Patrik Brundin & Jia-Yi Li, 2013, I : Neurobiology of Disease. 56C, April,30, s. 145-155

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration

    Kina Höglund, Nathalie Schussler, Hlin Kvartsberg, Una Smailovic, Gunnar Brinkmalm, Victor Liman, Bruno Becker, Henrik Zetterberg, Angel Cedazo-Minguez, Shorena Janelidze, Isabel A. Lefevre, Stéphanie Eyquem, Oskar Hansson & Kaj Blennow, 2020 feb, I : Neurobiology of Disease. 134, 104645.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Alterations of Akt1 (PKBalpha) and p70(S6K) in transient focal ischemia

    S Janelidze, BIng-Ren Hu, P Siesjö & B K Siesjö, 2001 feb, I : Neurobiology of Disease. 8, 1, s. 147-154

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration

    Itzia Jimenez, Michael Jewett, Ashmita Tontanahal, Marina Romero-Ramos & Maria Swanberg, 2017 okt 1, I : Neurobiology of Disease. 106, s. 279-290 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of L-DOPA-induced dyskinesia

    P. A. Johansson, M. Andersson, K. E. Andersson & M. A. Cenci, 2001, I : Neurobiology of Disease. 8, 2, s. 220-239 20 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands

    Deniz Kirik, Erik Cederfjäll, Glenda Halliday & Petersén, 2017 jan 1, I : Neurobiology of Disease. 97, s. 179-188 10 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  31. Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

    C Konradi, Jenny Westin, Manolo Carta, ME Eaton, Katarzyna Kuter, A Dekundy, Martin Lundblad & Angela Cenci Nilsson, 2004, I : Neurobiology of Disease. 17, 2, s. 219-236

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Special Issue: Viral delivery of genes: new frontiers Introduction

    Jeffrey H. Kordower & Deniz Kirik, 2012, I : Neurobiology of Disease. 48, 2, s. 151-152

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  33. Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis.

    Jennifer T Lamberts, Erin Hildebrandt & Patrik Brundin, 2015, I : Neurobiology of Disease. 77, Jul 15, s. 276-283

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  34. The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.

    Emma Lane, C Winkler, Patrik Brundin & Angela Cenci Nilsson, 2006, I : Neurobiology of Disease. 22, 2, s. 334-345

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.

    Emma Lane, Denis Soulet, L Vercammen, Angela Cenci Nilsson & Patrik Brundin, 2008, I : Neurobiology of Disease. 32, s. 220-228

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model

    Renata P. Lerner, Zisis Bimpisidis, Stergiani Agorastos, Sandra Scherrer, Stephen L. Dewey, Angela Cenci Nilsson & David Eidelberg, 2016 dec 1, I : Neurobiology of Disease. 96, s. 31-37 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. Cleavage of the vesicular glutamate transporters under excitotoxic conditions

    Andrea C. Lobo, Joao R. Gomes, Tatiana Catarino, Miranda Mele, Pedro Fernandez, Ana Inacio, Ben A. Bahr, Armanda E. Santos, Tadeusz Wieloch, Ana Luisa Carvalho & Carlos B. Duarte, 2011, I : Neurobiology of Disease. 44, 3, s. 292-303

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function.

    Martin Lundblad, B Picconi, Hanna Lindgren & Angela Cenci Nilsson, 2004, I : Neurobiology of Disease. 16, 1, s. 110-123

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.

    Matthew Maingay, Marina Romero-Ramos, Manolo Carta & Deniz Kirik, 2006, I : Neurobiology of Disease. 23, 3, s. 522-532

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice

    T M Malm, M Koistinaho, M Parepalo, T Vatanen, Andreas Ooka, Stefan Karlsson & J Koistinahoa, 2005, I : Neurobiology of Disease. 18, 1, s. 134-142

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. Re-evaluation of mitochondrial permeability transition as a primary neuroprotective target of minocycline.

    Roland Månsson, Magnus Hansson, Saori Morota, Hiroyuki Uchino, Christine Ekdahl Clementson & Eskil Elmer, 2007, I : Neurobiology of Disease. 25, s. 198-205

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to l-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels

    Flora Mela, Matteo Marti, Simone Bido, Angela Cenci Nilsson & Michele Morari, 2012, I : Neurobiology of Disease. 45, 1, s. 573-582

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. GABAA receptor dephosphorylation followed by internalization is coupled to neuronal death in in vitro ischemia.

    Miranda Mele, Luís Ribeiro, Ana Inacio, Tadeusz Wieloch & Carlos B Duarte, 2014, I : Neurobiology of Disease.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease

    Clarissa Ferolla Mendonça, Magdalena Kuras, Fábio César Sousa Nogueira, Indira Plá, Tibor Hortobágyi, László Csiba, Miklós Palkovits, Éva Renner, Péter Döme, György Marko-Varga, Gilberto B. Domont & Melinda Rezeli, 2019, I : Neurobiology of Disease. 130, 104509.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 Nästa